ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,004Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 1692

$445K Total Retail Price of All Prescriptions

Rank: 314 out of 1692

525 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,075 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 398 270 1 5
HYDROCODONE-ACETAMINOPHEN 378 270 S3 2 6
AMLODIPINE BESYLATE 357 265 3 3
SIMVASTATIN 329 202 4 1
HYDROCHLOROTHIAZIDE 320 251 5 9
FUROSEMIDE 316 278 6 7
LEVOTHYROXINE SODIUM 294 225 7 4
METFORMIN HCL 274 172 8 8
ENALAPRIL MALEATE 221 153 9 71
METOPROLOL TARTRATE 218 188 10 10
ATENOLOL 213 148 11 15
WARFARIN SODIUM 190 171 12 14
POTASSIUM CHLORIDE 179 156 13 20
GABAPENTIN 161 87 14 13
LISINOPRIL 153 113 15 2
TAMSULOSIN HCL 150 115 16 31
MELOXICAM 130 92 17 41
CARVEDILOL 120 119 18 24
SERTRALINE HCL 119 80 19 22
TRAZODONE HCL 105 87 20 33
PRAVASTATIN SODIUM 103 93 21 12
TRAMADOL HCL 98 51 22 16
ATORVASTATIN CALCIUM 96 38 23 11
LOSARTAN POTASSIUM 94 84 24 17
FLUTICASONE PROPIONATE 93 47 25 27
CITALOPRAM HBR 89 56 26 21
DONEPEZIL HCL 86 86 27 29
ALENDRONATE SODIUM 83 58 28 36
NAMENDA 81 81 29 50
ZETIA 79 67 30 68
NEXIUM 76 51 31 25
ZOLPIDEM TARTRATE 73 20 32 23
NAPROXEN 73 26 32 91
BENAZEPRIL HCL 71 38 34 69
GLIPIZIDE 69 52 35 47
ISOSORBIDE MONONITRATE ER 68 64 36 55
CYMBALTA 67 28 37 51
CRESTOR 66 35 38 26
AZITHROMYCIN 62 40 39 34
VENLAFAXINE HCL ER 62 53 39 84
PANTOPRAZOLE SODIUM 62 47 39 39
GLIPIZIDE XL 61 60 42 131
AVODART 59 59 43 173
RISPERIDONE 57 57 44 77
AMLODIPINE BESYLATE-BENAZEPRIL 55 46 45 67
QUETIAPINE FUMARATE 55 55 45 62
IBUPROFEN 54 25 47 78
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 32 47 19
MIRTAZAPINE 53 33 49 53
GLIPIZIDE ER 52 44 50 87
SYMBICORT 51 29 51 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.